SpineGuard SA Stocks

0.12Last Updated 02.03.2026

Issuer Rating

2/7

Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

€ 9.03M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
0.12
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

SpineGuard SA provides designs, develops, and markets medical devices used in surgical procedures worldwide. The company provides PediGuard Straight probe for screw placement; PediGuard Curved probe that includes a tapered tip to enhance the ease of penetrating through pedicle; PediGuard Cannulated probe primarily for helping surgeons reduce radiation exposure during minimally-invasive procedures; and PediGuard Threaded...

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks